Stephen T. Oh, Ph.D.
Affiliations: | 2002 | Northwestern University, Evanston, IL |
Area:
Molecular BiologyGoogle:
"Stephen Oh"Parents
Sign in to add mentor| Laimonis Laimins | grad student | 2002 | Northwestern | |
| (Functions of high-risk and low-risk human papillomavirus E6 and E7 proteins.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Oh ST, Talpaz M, Gerds AT, et al. (2020) ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial. Blood Advances. 4: 4282-4291 |
| Grunwald MR, Kuter DJ, Altomare I, et al. (2019) Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study. Clinical Lymphoma, Myeloma & Leukemia |
| Dao KT, Gotlib J, Deininger MMN, et al. (2019) Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900895 |
| Zhang H, Wilmot B, Bottomly D, et al. (2019) Genomic landscape of Neutrophilic Leukemias of Ambiguous Diagnosis. Blood |
| Fisher DAC, Miner CA, Engle EK, et al. (2019) Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling. Leukemia |
| Fuh KC, Lomonosova E, Guo L, et al. (2019) Identifying a potential biomarker for anti-PD-1 immunotherapy in patients with advanced stage, surgically-resectable endometrial cancer. Journal of Clinical Oncology. 37: 5590-5590 |
| Wang T, Sun H, Cui Zhou D, et al. (2019) Single-Cell Pathway Enrichment and Regulatory Profiling of Multiple Myeloma across Disease Stages Blood. 134: 364-364 |
| Fowles JS, Fisher DA, Zhou A, et al. (2019) Altered Dynamics of Monocyte Subpopulations and Pro-Inflammatory Signaling Pathways in Polycythemia Vera Revealed By Mass Cytometry Blood. 134: 4210-4210 |
| Collins TB, Luff SA, Batista LF, et al. (2019) Interrogating the Role of ASXL1 and JAK2 mutations in Myeloproliferative Neoplasms Utilizing Human Pluripotent Stem Cells Blood. 134: 2971-2971 |
| O'Sullivan J, Taylor JA, Gerds AT, et al. (2019) Molecular Analysis in the Pacritinib Dose-Finding PAC203 Study in Patients with Myelofibrosis Refractory or Intolerant to Ruxolitinib Blood. 134: 4214-4214 |